Boutrel Benjamin, Monaca Christelle, Hen Rene, Hamon Michel, Adrien Joelle
Institut National de la Santé et de la Recherche Médicale U288, NeuroPsychoPharmacologie Moléculaire, Cellulaire et Fonctionnelle, Faculté de Médicine Pitié-Salpêtrière, 75634 Paris Cedex 13, France.
J Neurosci. 2002 Jun 1;22(11):4686-92. doi: 10.1523/JNEUROSCI.22-11-04686.2002.
For the last two decades, the involvement of 5-HT(1A) receptors in the regulation of vigilance states has been studied extensively thanks to pharmacological tools, but clear-cut conclusion has not been reached yet. By studying mutant mice that do not express this receptor type (5-HT(1A)-/-) and their wild-type 129/Sv counterparts, we herein demonstrate that 5-HT(1A) receptors play key roles in the control of spontaneous sleep-wakefulness cycles, as well as in homeostatic regulation and stress-induced adaptive changes of paradoxical sleep. Both strains of mice exhibited a diurnal sleep-wakefulness rhythm, but 5-HT(1A)-/- animals expressed higher amounts of paradoxical sleep than wild-type mice during both the light and the dark phases. In wild-type mice, pharmacological blockade of 5-HT(1A) receptors by WAY 100635 (0.5 mg/kg, i.p.) promoted paradoxical sleep, whereas the 5-HT(1A) agonist 8-OH-DPAT (0.25-1 mg/kg, s.c.) had an opposite effect. In contrast, none of the 5-HT(1A) receptor ligands affected sleep significantly in 5-HT(1A)-/- mice. However, 5-HT(1B) receptor stimulation by CP 94253 (1-3 mg/kg, i.p.) induced a reduction in paradoxical sleep in both strains, this effect being more pronounced in 5-HT(1A)-/- mutants. Finally, in contrast to wild-type mice, 5-HT(1A)-/- mutants did not exhibit any rebound of paradoxical sleep after either a 9 hr instrumental paradoxical sleep deprivation or a 90 min immobilization stress. Altogether, these data indicate that, in the mouse, 5-HT(1A) receptors participate in the spontaneous and homeostatic regulation, as well as in stress-induced adaptive changes of paradoxical sleep.
在过去二十年中,借助药理学工具,人们对5-羟色胺(5-HT)1A受体在警觉状态调节中的作用进行了广泛研究,但尚未得出明确结论。通过研究不表达这种受体类型(5-HT(1A)-/-)的突变小鼠及其野生型129/Sv同窝小鼠,我们在此证明5-HT(1A)受体在自发睡眠-觉醒周期的控制中起关键作用,以及在异相睡眠的稳态调节和应激诱导的适应性变化中起关键作用。两种品系的小鼠均表现出昼夜睡眠-觉醒节律,但在光照和黑暗阶段,5-HT(1A)-/-动物的异相睡眠量均高于野生型小鼠。在野生型小鼠中,WAY 100635(0.5毫克/千克,腹腔注射)对5-HT(1A)受体的药理学阻断促进了异相睡眠,而5-HT(1A)激动剂8-羟基二丙胺基四氢萘(8-OH-DPAT,0.25-1毫克/千克,皮下注射)则具有相反的作用。相比之下,5-HT(1A)受体配体对5-HT(1A)-/-小鼠的睡眠均无显著影响。然而,CP 94253(1-3毫克/千克,腹腔注射)对5-HT(1B)受体的刺激在两种品系中均导致异相睡眠减少,这种效应在5-HT(1A)-/-突变体中更为明显。最后,与野生型小鼠不同,5-HT(1A)-/-突变体在9小时工具性异相睡眠剥夺或90分钟固定应激后均未表现出任何异相睡眠反弹。总之,这些数据表明,在小鼠中,5-HT(1A)受体参与异相睡眠的自发和稳态调节,以及应激诱导的适应性变化。